Business Wire

Adtran builds on 30-year legacy of US telecommunications equipment manufacturing through strategic investment to support historic high-speed internet deployment

Share

Adtran today announced the expansion of advanced telecommunications equipment manufacturing at its state-of-the-art facility in Huntsville, Alabama, to meet the growing demand for domestically produced network electronics, spurred by the Biden-Harris Administration’s $42.45 billion Broadband Equity, Access and Deployment (BEAD) Program and its Made-in-America policies in the Bipartisan Infrastructure Law.

With a total investment of up to $5 million and the creation of up to 300 high-quality, good-paying jobs, today’s announcement is an exciting step forward in Adtran’s decades-long journey to make communications simpler and more affordable for millions of Americans.

Adtran is expanding its current US production of optical line termination (OLT) equipment and preparing to onshore the manufacturing of optical network terminals (ONTs).

To celebrate this announcement, Adtran is welcoming Mitch Landrieu, Senior Advisor to the President and White House Infrastructure Coordinator, and Alan Davidson, Assistant Secretary of Commerce for Communications and Information and NTIA Administrator, for a tour of its 270,000-square-foot manufacturing facility.

“As a leading US telecommunications equipment provider, we look forward to partnering with state broadband offices and network operators across the country as they expand secure, high-speed internet access to millions of Americans,” said Tom Stanton, CEO of Adtran. “This expansion not only represents a strategic investment in Adtran’s growing workforce and manufacturing capabilities but also demonstrates our long-term commitment to strengthening the domestic supply chain and securing communications networks with American-made equipment.”

Adtran is excited to welcome new employees to its team and is committed to investing in their success with on-the-job training and by extending the same industry-leading benefits it offers its current employees, including a college tuition reimbursement program.

Adtran is investing in the community by partnering with local area schools for its high school apprenticeship program and developing a co-op program for college students. The diversity of Adtran’s workforce reflects the diversity of Alabama: People of color make up over 40% of Adtran’s manufacturing team and one-third identify as African American. 57% of manufacturing employees are women, compared to a manufacturing industry average of just 30%.

“This announcement is the latest example of how we’re turning ‘Made in America’ into a reality and expanding manufacturing across the country,” commented Gina Raimondo, US Secretary of Commerce. “Thanks to President Biden’s Investing in America agenda, we will connect everyone in America to high-speed internet networks built by American workers with American-made equipment.”

“The Internet for All initiative is not just a connectivity program, it’s a jobs program – for the people who build the networks and for the people who make the equipment those networks need,” said Alan Davidson, Assistant Secretary of Commerce for Communications and Information and NTIA Administrator. “If network equipment can be made in America, it should be made in America. Companies like Adtran are stepping up and answering that call.”

“Access to high-speed internet is no longer a luxury – it is an essential tool to access education, healthcare and jobs,” commented Mitch Landrieu, Senior Advisor to the President and White House Infrastructure Coordinator. “President Biden’s Investing in America agenda has made the largest investment in high-speed internet in our country’s history to ensure all Americans are connected to affordable, reliable high-speed internet using Made-in-America materials. Adtran’s exciting announcement today is part of a manufacturing boom that is creating good-paying jobs and boosting our economy – including here in Huntsville, Alabama.”

“The Tennessee Valley has long been a national leader in developing the advanced technologies that support our modern industrial base. The investments announced today will help ensure that broadband is able to reach more Americans with equipment made right here in North Alabama, supporting our economy and the United States as a whole,” noted Dale Strong, US Representative (AL-05).

About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and Twitter.

Published by
ADTRAN Holdings, Inc.
www.adtran.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media
Rob Snyder
+1 256 963 6383
public-relations@adva.com

For investors
Steven Williams
+49 89 890 665 918
investor@adtran.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 13:30:00 EET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations for treatment-resistant depression (TRD) from 10:00-11:30 am ET on January 7th. “PTSD is one of the most challenging mental health conditions, with approximately 13 million adults in the U.S. living with persistent symptoms and limited treatment options,” said Dr. Guy Goodwin, Chief Medical Officer at Compass Pathways. “We are pleased to advance our clinical development - the unmet need is profound, and it demands bold innovation. We believe COMP360 has the potential to tra

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release

I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci

RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 10:00:00 EET | Press release

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye